Kampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice

Evidence-based Complementary and Alternative Medicine

Volumn 2, Issue 2, 2005, Pages 191-199

  Xiu, Kun Gao ^a   Fuseda, Kazutoshi ^a   Shibata, Tomonori ^a   Tanaka, Hiroyuki ^a   Inagaki, Naoki ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Herbal medicine; IgE; Th1 Th2 balance

Indexed keywords

ANTIGEN; BU ZHONG YI QI TANG; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; KAMPO; MESSENGER RNA; ORENGEDOKU TO; PLANT EXTRACT; SHI QUAN DA BU TANG; SHOFU SAN EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CERVICAL LYMPH NODE; CONTROLLED STUDY; DRUG ACTIVITY; EAR LOBE; EDEMA; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; MITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; TH1 CELL; TH2 CELL;

EID: 24344475569     PISSN: 1741427X     EISSN: None     Source Type: Journal    
DOI: 10.1093/ecam/neh077     Document Type: Article

References (38)

1. Furue M, Furukawa F, Hide M, Takehara K. Guidelines for therapy for atopic dermatitis 2004. Jpn J Dermatol 2004;114:135-42.
2. Wahlgren CF. Pathophysiology of itching in urticaria and atopic dermatitis. Allergy 1992;47:65-75.
3. Hoffman DR, Yamamoto FY, Geller B, Haddad Z. Specific IgE antibodies in atopic eczema. J Allergy Clin Immunol 1975;55:256-67.
4. Sampson HA, Albergo R. Comparison of results of prick skin tests, RAST, and double-blind placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 1984;74:26-33.
5. Barnetson RS, White AD. The use of corticosteroids in dermatological practice. Med J Aust 1992;156:428-31.
6. Leung AK, Barber KA. Managing childhood atopic dermatitis. Adv Ther 2003;20:129-37.
7. Nakagawa H, Etoh T, Ishibashi Y, et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994;344:883.
8. Bieber T. Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis. J Allergy Clin Immunol 1998;102:555-7.
9. Shih FJ. Concepts related to Chinese patients' perceptions of health, illness and person: issues of conceptual clarity. Accid Emerg Nurs 1996;4:208-15.
10. Meng A. Principles of traditional Chinese medicine. Wien Med Wochenschr 2000;150:310-6.
11. Yuan R, Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther 2000;86:191-8.
12. Koo J, Desai R. Traditional Chinese medicine in dermatology. Dermatol Ther 2003;16:98-105.
13. Gao XK, Nakamura N, Fuseda K, Tanaka H, Inagaki N, Nagai H. Establishment of an allergic dermatitis in NC/Nga mice as a model for severe atopic dermatitis. Biol Pharm Bull 2004;27:1376-81.
14. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004;113:395-400.
15. McGeady SJ. Immunocompetence and allergy. Pediatrics 2004; 113:1107-13.
16. Japanese Association for Laboratory Animal Science. Guideline for animal experimentation. Exp Anim 1987;36:285-8.
17. Koda A, Inagaki N, Tsuruoka N, et al. Specific suppression of antigen-antibody reactions by a dialysate from Dermatophagoides farinae. J Pharmacobio Dyn 1987;10:104-11.
18. Hsiang CY, Lai IL, Chao DV, Ho TY. Differential regulation of activator protein 1 activity by glycyrrhizin. Life Sci 2002;70:1643-56.
19. Wei F, Zou S, Young A, Dubner R, Ren K. Effects of four herbal extracts on adjuvant-induced inflammation and hyperalgesia in rats. J Altern Complement Med 1999;5:429-36.
20. Hsieh CC, Lin WC, Lee MR, et al. Dang-Gui-Bu-Xai-Tang modulate the immunity of tumor bearing mice. Immunopharmacol Immunotoxicol 2003;25:259-71.
21. Oka H, Ohno N, Iwanaga S, et al. Characterization of mitogenic substances in the hot water extracts of bupleuri radix. Biol Pharm Bull 1995;18:757-65.
22. Koda A, Nagai H, Wada H. Pharmacological actions of baicalin and baicalein. I. On active anaphylaxis. Nippon Yakurigaku Zasshi 1970;66:194-213.
23. Chi YS, Lim H, Park H, Kim HP. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol 2003;66:1271-8.
24. Ckless K, Schlottfeldt JL, Pasqual M, Moyna P, Henriques JA, Wajner M. Inhibition of in-vitro lymphocyte transformation by the isoquinoline alkaloid berberine. J Pharm Pharmacol 1995;47:1029-31.
25. Iijima K, Sun S, Cyong JC, Jyonouchi H. Juzen-taiho-to, a Japanese herbal medicine, modulates type 1 and type 2 T cell responses in old BALB/c mice. Am J Clin Med 1999;27:191-203.
26. Matsumoto T, Yamada H. Orally administered Kampo (Japanese herbal) medicine, "Juzen-taiho-to" modulates cytokine secretion in gut associated lymphoreticular tissues in mice. Phytomedicine 2000;6:425-30.
27. Ishimitsu R, Nishimura H, Kawauchi H, Kawakita T, Yoshikai Y. Dichotomous effect of a traditional Japanese medicine, bu-zhong-yi-qi-tang on allergic asthma in mice. Int Immunopharmacol 2001;1:857-65.
28. Kaneko M, Kishihara K, Kawakita T, Nakamura T, Takimoto H, Nomoto K. Suppression of IgE production in mice treated with a traditional Chinese medicine, bu-zhong-yi-qi-tang (Japanese name: hochu-ekki-to). Immunopharmacology 1997;36:79-85.
29. Nakada T, Watanabe K, Matsumoto T, Santa K, Triizuka K, Hanawa T. Effect of orally administered Hochu-ekki-to, a Japanese herbal medicine, on contact hypersensitivity caused by repeated application of antigen. Int Immunopharmacol 2002;2:901-11.
30. Yamaoka Y, Kawakita T, Kishihara K, Nomoto K. Effect of a traditional Chinese medicine, Bu-zhong-yi-qi-tang on the protection against an oral infection with Listeria monocytogenes. Immunopharmacology 1998;39:215-23.
31. Li T, Tamada K, Abe K, et al. The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang). Immunopharmacology 1999;43:11-21.
32. Kobayashi H, Mizuno N, Kutsuna H, et al. Hochu-ekki-to suppresses development of dermatitis and elevation of serum IgE level in NC/Nga mice. Drugs Exp Clin Res 2003;29:81-4.
33. Akamatsu H, Asada Y, Horio T. Inhibitory effect of shofu-san, a Japanese kampo medicine, on neutrophil functions in vitro. Am J Clin Med 1998;26:57-64.
34. Nose M, Sakushima J, Harada D, Ogihara Y. Comparison of immunopharmacological actions of 8 kinds of kampo-hozai clinically used in atopic dermatitis on delayed-type hypersensitivity in mice. Biol Pharm Bull 1999;22:48-54.
35. Wang LM, Yamamoto T, Wang XX, et al. Effects of oren-gedoku-to and unsei-in, Chinese traditional medicines, on interleukin-8 and superoxide dismutase in rats. J Pharm Pharmacol 1997;49:102-4.
36. Fukutake M, Miura N, Yamamoto M, et al. Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats. Cancer Lett 2000;157:9-14.
37. Matsuda H, Watanabe N, Geba GP, et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-6.
38. Tsidzuki M, Watanabe N, Wada A, Nakane Y, Hiroi J, Matsuda H. Genetic analyses for dermatitis and IgE hyperproduction in the NC/Nga mouse. Immunogenetics 1997;47:88-90.